Systemic Treatment of Vitreous Inflammation

المؤلفون المشاركون

Christoforidis, John
Chang, Susie
Cebulla, Colleen M.
Jiang, Angela
Wang, Jillian

المصدر

Mediators of Inflammation

العدد

المجلد 2012، العدد 2012 (31 ديسمبر/كانون الأول 2012)، ص ص. 1-10، 10ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2012-09-16

دولة النشر

مصر

عدد الصفحات

10

التخصصات الرئيسية

الأمراض

الملخص EN

Non infectious vitreous inflammation is often vision threatening and can be associated with potentially life-threatening systemic conditions.

Treatment is often challenging as it involves systemic medications that can be associated with adverse effects.

The classes of drugs are ever expanding and include corticosteroids, antimetabolites, alkylating agents, T-cell and calcineurin agents, biologic agents, and interferons.

Each class of systemic therapy for non-infectious vitreous inflammation is reviewed.

We discuss the mechanisms of action, usual clinical dosages, the specific conditions that are treated, the adverse effects, and usual course of treatment for each class of therapy.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Christoforidis, John& Chang, Susie& Jiang, Angela& Wang, Jillian& Cebulla, Colleen M.. 2012. Systemic Treatment of Vitreous Inflammation. Mediators of Inflammation،Vol. 2012, no. 2012, pp.1-10.
https://search.emarefa.net/detail/BIM-1029455

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Christoforidis, John…[et al.]. Systemic Treatment of Vitreous Inflammation. Mediators of Inflammation No. 2012 (2012), pp.1-10.
https://search.emarefa.net/detail/BIM-1029455

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Christoforidis, John& Chang, Susie& Jiang, Angela& Wang, Jillian& Cebulla, Colleen M.. Systemic Treatment of Vitreous Inflammation. Mediators of Inflammation. 2012. Vol. 2012, no. 2012, pp.1-10.
https://search.emarefa.net/detail/BIM-1029455

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1029455